+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Wound Gel Market Size, Share & Trends Analysis Report By Product (Dressings, Gels), By Antimicrobial Properties (Silver (Ag+), Non-Silver), By Application, By End-use, By Mode Of Purchase, By Distribution Channel, And Segment Forecasts, 2025 - 2033

  • PDF Icon

    Report

  • 100 Pages
  • June 2025
  • Region: United States
  • Grand View Research
  • ID: 6111476

U.S Wound Gel Market Size & Trends

The U.S. wound gel market size was estimated at USD 2.11 billion in 2024 and is expected to grow at a CAGR of 5.71% from 2025 to 2033 to reach USD 3.47 billion by 2033. This growth is attributed to the rising prevalence of chronic wounds, increasing demand for advanced wound care solutions, a growing elderly population, and continuous innovations in hydrogel formulations that enhance healing outcomes. In addition, the shift toward outpatient and home-based care and supportive reimbursement policies is further accelerating market expansion.

According to data from the U.S. Census Bureau, by 2025, the population's average age is expected to reach 40 years, with approximately 60 million individuals aged 65 years or older accounting for 18% of the total population. Among them, 4% will be 80 years or older. By 2050, the number of elderly individuals is projected to rise to 80 million, representing 25% of the population aged 65 and above, while those aged 80 and over will comprise 8%.

The increasing demand for wound gel products from the U.S. military and defense sector is emerging as a significant market driver, primarily due to combat and field operations' unique and high-risk nature. Military personnel are frequently exposed to traumatic injuries, including lacerations, burns, and deep wounds, which require immediate, efficient, and infection-resistant treatment in austere environments where traditional surgical care is not readily available. In such scenarios, wound gels offer a practical solution-they are portable, easy to apply, and provide moisture-retentive healing environments that promote faster tissue regeneration while minimizing infection risks.

Furthermore, the U.S. Department of Defense has collaborated with biotechnology firms to develop advanced hydrogel formulations, including enzyme-based or antimicrobial wound gels designed specifically for battlefield use. For instance, in November 2024, the U.S. Army partnered with SolasCure, a Cambridge-based biotechnology company, to evaluate the company's investigational wound care hydrogel, Aurase Wound Gel, in military settings. Aurase wound gel features a recombinant enzyme, tarumase, derived initially from maggots. This enzyme is highly effective in enzymatic debridement, removing dead tissue and preparing the wound bed, offering a biologically inspired solution for wound management that supports natural and alternative healing approaches.

U.S. Wound Gel Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. wound gel market report based on product, antimicrobial properties, application, distribution channel, mode of purchase, and end-use:

Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Dressings
  • Hydrogel dressing
  • Gelling fiber dressings
  • Others
  • Gels

Antimicrobial Properties Outlook (Revenue, USD Million, 2021 - 2033)

  • Silver (Ag+)
  • Non-Silver

Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Chronic Wounds
  • Diabetic Foot Ulcers (DFUs)
  • Pressure Ulcers
  • Stage 1
  • Stage 2
  • Stage 3
  • Stage 4
  • Leg Ulcers
  • Acute Wounds
  • Surgical Incisions
  • Burns
  • 1st Degree
  • 2nd Degree
  • 3rd Degree
  • Lacerations, Abrasions

Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)

  • Prescription
  • Non-prescription

Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Offline
  • Online

End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Homecare Settings
  • Long-Term Care Facilities
  • Others

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Antimicrobial Properties
1.2.3. Application
1.2.4. Distribution Channel
1.2.5. Mode of Purchase
1.2.6. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Wound Gel Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Shift towards home healthcare
3.2.1.2. Technological advancements
3.2.1.3. Rising Prevalence of Chronic Diseases
3.2.1.4. Rising aging population in the U.S.
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulatory environment
3.2.2.2. Limited reimbursement policies
3.2.3. Market Opportunities Analysis
3.2.3.1. Increasing demand for wound gel products from the military and defense sector
3.2.4. Market Challenge Analysis
3.2.4.1. Rising competition among industry participants
3.3. U.S. Wound Gel Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. Wound Gel Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Wound Gel Market Movement Analysis
4.3. U.S. Wound Gel Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
4.4. Dressings
4.4.1. Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Hydrogel Dressing
4.4.2.1. Hydrogel Dressing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Gelling Fiber Dressings
4.4.3.1. Gelling Fiber Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Others
4.4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Gels
4.5.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Wound Gel Market: Antimicrobial Properties Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Wound Gel Market Movement Analysis
5.3. U.S. Wound Gel Market Size & Trend Analysis, by Antimicrobial Properties, 2021 to 2033 (USD Million)
5.4. Silver (Ag+)
5.4.1. Silver (Ag+) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Non-Silver
5.5.1. Non-Silver Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Wound Gel Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Wound Gel Market Movement Analysis
6.3. U.S. Wound Gel Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Chronic Wounds
6.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. Diabetic Foot Ulcers (DFUs)
6.4.2.1. Diabetic Foot Ulcers (DFUs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Pressure Ulcers
6.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3.2. Stage 1
6.4.3.2.1. Stage 1 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3.3. Stage 2
6.4.3.3.1. Stage 2 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3.4. Stage 3
6.4.3.4.1. Stage 3 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3.5. Stage 4
6.4.3.5.1. Stage 4 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Leg Ulcers
6.4.4.1. Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Acute Wounds
6.5.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. Surgical Incisions
6.5.2.1. Surgical Incisions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Burns
6.5.3.1. Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3.2. 1st Degree
6.5.3.2.1. 1st Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3.3. 2nd Degree
6.5.3.3.1. 2nd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3.4. 3rd Degree
6.5.3.4.1. 3rd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. Lacerations, Abrasions
6.5.4.1. Lacerations, Abrasions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Wound Gel Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Wound Gel Market Movement Analysis
7.3. U.S. Wound Gel Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
7.4. Online
7.4.1. Online Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Offline
7.5.1. Offline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. U.S. Wound Gel Market: Mode of Purchase Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. U.S. Wound Gel Market Movement Analysis
8.3. U.S. Wound Gel Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
8.4. Prescription
8.4.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Non-prescription
8.5.1. Non-prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. U.S. Wound Gel Market: End Use Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. U.S. Wound Gel Market Movement Analysis
9.3. U.S. Wound Gel Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.4. Hospitals
9.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Specialty Clinics
9.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Ambulatory Surgery Center
9.6.1. Ambulatory Surgery Center Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. Homecare Settings
9.7.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.8. Long-Term Care Facilities
9.8.1. Long-Term Care Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.9. Others
9.9.1. Long-term Care (residential living setting) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.2. Key Company Profiles
10.3. Company Share Analysis, 2024
10.3.1. Medline Industries, LP.
10.3.1.1. Company Overview
10.3.1.2. Financial Performance
10.3.1.3. Product Benchmarking
10.3.1.4. Strategic Initiatives
10.3.2. Coloplast Corp
10.3.2.1. Company Overview
10.3.2.2. Financial Performance
10.3.2.3. Product Benchmarking
10.3.2.4. Strategic Initiatives
10.3.3. Mölnlycke Health Care AB
10.3.3.1. Company Overview
10.3.3.2. Financial Performance
10.3.3.3. Product Benchmarking
10.3.3.4. Strategic Initiatives
10.3.4. Solventum
10.3.4.1. Company Overview
10.3.4.2. Financial Performance
10.3.4.3. Product Benchmarking
10.3.4.4. Strategic Initiatives
10.3.5. Convatec Inc.
10.3.5.1. Company Overview
10.3.5.2. Financial Performance
10.3.5.3. Product Benchmarking
10.3.5.4. Strategic Initiatives
10.3.6. Cresilon
10.3.6.1. Company Overview
10.3.6.2. Financial Performance
10.3.6.3. Product Benchmarking
10.3.6.4. Strategic Initiatives
10.3.7. Smith+Nephew
10.3.7.1. Company Overview
10.3.7.2. Financial Performance
10.3.7.3. Product Benchmarking
10.3.7.4. Strategic Initiatives
10.3.8. B. Braun SE
10.3.8.1. Company Overview
10.3.8.2. Financial Performance
10.3.8.3. Product Benchmarking
10.3.8.4. Strategic Initiatives
10.3.9. DermaRite Industries, LLC.
10.3.9.1. Company Overview
10.3.9.2. Financial Performance
10.3.9.3. Product Benchmarking
10.3.9.4. Strategic Initiatives
10.3.10. Integra LifeSciences Corporation
10.3.10.1. Company Overview
10.3.10.2. Financial Performance
10.3.10.3. Product Benchmarking
10.3.10.4. Strategic Initiatives
10.3.11. Sanara MedTech Inc.
10.3.11.1. Company Overview
10.3.11.2. Financial Performance
10.3.11.3. Product Benchmarking
10.3.11.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. Wound Gel Market, by Product, 2021 - 2033 (USD Million)
Table 4. U.S. Wound Gel Market, by Antimicrobial Properties, 2021 - 2033 (USD Million)
Table 5. U.S. Wound Gel Market, by Application, 2021 - 2033 (USD Million)
Table 6. U.S. Wound Gel Market, by Distribution Channel, 2021 - 2033 (USD Million)
Table 7. U.S. Wound Gel Market, by Mode of Purchase, 2021 - 2033 (USD Million)
Table 8. U.S. Wound Gel Market, by End Use, 2021 - 2033 (USD Million)
Table 9. Participant’s Overview
Table 10. Financial Performance
Table 11. Product Benchmarking
Table 12. Strategic Initiatives
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 U.S. Wound Gel Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 U.S. Wound Gel Market, for Product, 2021 - 2033 (USD Million)
Fig. 15 U.S. Wound Gel Market, for Dressings, 2021 - 2033 (USD Million)
Fig. 16 U.S. Wound Gel Market, for Hydrogel Dressing, 2021 - 2033 (USD Million)
Fig. 17 U.S. Wound Gel Market, for Gelling Fiber Dressings, 2021 - 2033 (USD Million)
Fig. 18 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
Fig. 19 U.S. Wound Gel Market, for Gels, 2021 - 2033 (USD Million)
Fig. 20 U.S. Wound Gel Market, for Antimicrobial Properties, 2021 - 2033 (USD Million)
Fig. 21 U.S. Wound Gel Market, for Silver (Ag+), 2021 - 2033 (USD Million)
Fig. 22 U.S. Wound Gel Market, for Non-Silver, 2021 - 2033 (USD Million)
Fig. 23 U.S. Wound Gel Market, for Application, 2021 - 2033 (USD Million)
Fig. 24 U.S. Wound Gel Market, for Chronic Wounds, 2021 - 2033 (USD Million)
Fig. 25 U.S. Wound Gel Market, for Diabetic Foot Ulcers (DFUs), 2021 - 2033 (USD Million)
Fig. 26 U.S. Wound Gel Market, for Pressure Ulcers, 2021 - 2033 (USD Million)
Fig. 27 U.S. Wound Gel Market, for Stage 1, 2021 - 2033 (USD Million)
Fig. 28 U.S. Wound Gel Market, for Stage 2, 2021 - 2033 (USD Million)
Fig. 29 U.S. Wound Gel Market, for Stage 3, 2021 - 2033 (USD Million)
Fig. 30 U.S. Wound Gel Market, for Stage 4, 2021 - 2033 (USD Million)
Fig. 31 U.S. Wound Gel Market, for Leg Ulcers, 2021 - 2033 (USD Million)
Fig. 32 U.S. Wound Gel Market, for Acute Wound, 2021 - 2033 (USD Million)
Fig. 33 U.S. Wound Gel Market, for Surgical Incisions, 2021 - 2033 (USD Million)
Fig. 34 U.S. Wound Gel Market, for Burns, 2021 - 2033 (USD Million)
Fig. 35 U.S. Wound Gel Market, for 1st Degree, 2021 - 2033 (USD Million)
Fig. 36 U.S. Wound Gel Market, for 2nd Degree, 2021 - 2033 (USD Million)
Fig. 37 U.S. Wound Gel Market, for 3rd Degree, 2021 - 2033 (USD Million)
Fig. 38 U.S. Wound Gel Market, for Lacerations, Abrasions, 2021 - 2033 (USD Million)
Fig. 39 U.S. Wound Gel Market, for End Use, 2021 - 2033 (USD Million)
Fig. 40 U.S. Wound Gel Market, for Hospitals, 2021 - 2033 (USD Million)
Fig. 41 U.S. Wound Gel Market, for Specialty Clinics, 2021 - 2033 (USD Million)
Fig. 42 U.S. Wound Gel Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
Fig. 43 U.S. Wound Gel Market, for Homecare Settings, 2021 - 2033 (USD Million)
Fig. 44 U.S. Wound Gel Market, for Long-Term Care Facilities, 2021 - 2033 (USD Million)
Fig. 45 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
Fig. 46 U.S. Wound Gel Market, for Distribution Channel, 2021 - 2033 (USD Million)
Fig. 47 U.S. Wound Gel Market, for Offline, 2021 - 2033 (USD Million)
Fig. 48 U.S. Wound Gel Market, for Online, 2021 - 2033 (USD Million)
Fig. 49 U.S. Wound Gel Market, for Mode of Purchase, 2021 - 2033 (USD Million)
Fig. 50 U.S. Wound Gel Market, for Prescription, 2021 - 2033 (USD Million)
Fig. 51 U.S. Wound Gel Market, for Non-prescription, 2021

Companies Mentioned

  • Medline Industries, LP.
  • Coloplast Corp
  • Mölnlycke Health Care AB
  • Solventum
  • Convatec Inc.
  • Cresilon
  • Smith+Nephew.
  • B. Braun SE
  • DermaRite Industries, LLC.
  • Integra LifeSciences Corporation.
  • Sanara MedTech Inc.

Table Information